X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5251) 5251
Book Review (1585) 1585
Publication (219) 219
Book Chapter (40) 40
Book / eBook (32) 32
Conference Proceeding (12) 12
Magazine Article (6) 6
Web Resource (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4799) 4799
humans (4546) 4546
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (3225) 3225
male (1670) 1670
platelet aggregation inhibitors - therapeutic use (1622) 1622
female (1468) 1468
cardiac & cardiovascular systems (1319) 1319
middle aged (1176) 1176
abridged index medicus (1124) 1124
animals (1122) 1122
hematology (1048) 1048
aged (1006) 1006
platelet aggregation inhibitors - pharmacology (891) 891
peripheral vascular disease (878) 878
treatment outcome (878) 878
platelet aggregation - drug effects (818) 818
platelets (718) 718
angioplasty, balloon, coronary (711) 711
blood platelets - drug effects (635) 635
antibodies, monoclonal - therapeutic use (633) 633
blood platelets - metabolism (615) 615
thrombosis (614) 614
immunoglobulin fab fragments - therapeutic use (613) 613
abciximab (610) 610
platelet glycoprotein gpiib-iiia complex - metabolism (603) 603
platelet aggregation inhibitors - administration & dosage (574) 574
tyrosine - analogs & derivatives (570) 570
myocardial infarction - drug therapy (557) 557
stents (541) 541
angioplasty (540) 540
myocardial infarction - therapy (532) 532
platelet aggregation inhibitors - adverse effects (514) 514
acute coronary syndromes (513) 513
acute myocardial-infarction (508) 508
percutaneous coronary intervention (488) 488
risk factors (482) 482
drug therapy, combination (480) 480
aggregation (479) 479
anticoagulants - therapeutic use (478) 478
unstable angina (468) 468
pharmacology & pharmacy (462) 462
time factors (456) 456
aspirin (448) 448
cardiology (448) 448
fibrinolytic agents - therapeutic use (447) 447
blood platelets (442) 442
adult (428) 428
heart attacks (396) 396
platelet aggregation (396) 396
ticlopidine - analogs & derivatives (392) 392
blood platelets - physiology (371) 371
aspirin - therapeutic use (367) 367
mortality (353) 353
drug therapy (352) 352
platelet activation (349) 349
platelet activation - drug effects (349) 349
randomized controlled trials as topic (349) 349
clopidogrel (341) 341
heparin - therapeutic use (334) 334
dose-response relationship, drug (333) 333
myocardial-infarction (326) 326
peptides - therapeutic use (326) 326
tyrosine - therapeutic use (321) 321
activation (317) 317
ticlopidine - therapeutic use (312) 312
coronary disease - drug therapy (310) 310
antibodies, monoclonal - pharmacology (301) 301
thrombolytic therapy (301) 301
acute disease (297) 297
tirofiban (290) 290
mice (289) 289
medicine & public health (287) 287
fibrinogen (285) 285
trial (285) 285
coronary angiography (283) 283
medicine, general & internal (283) 283
clinical trials as topic (281) 281
myocardial infarction - mortality (280) 280
electrocardiography (278) 278
coronary disease - therapy (277) 277
inhibition (277) 277
platelet (277) 277
angina, unstable - drug therapy (274) 274
fibrinogen - metabolism (271) 271
hemorrhage - chemically induced (271) 271
flow cytometry (267) 267
angioplasty, balloon, coronary - adverse effects (261) 261
therapy (259) 259
anticoagulants (254) 254
eptifibatide (251) 251
coronary heart disease (242) 242
follow-up studies (241) 241
receptor (240) 240
immunoglobulin fab fragments - administration & dosage (237) 237
antibodies, monoclonal - administration & dosage (236) 236
p-selectin (236) 236
heparin (234) 234
immunoglobulin fab fragments - pharmacology (234) 234
care and treatment (232) 232
prospective studies (231) 231
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5067) 5067
German (72) 72
French (52) 52
Spanish (30) 30
Italian (29) 29
Russian (21) 21
Japanese (10) 10
Portuguese (10) 10
Polish (8) 8
Chinese (6) 6
Danish (6) 6
Hungarian (5) 5
Dutch (4) 4
Serbian (3) 3
Hebrew (2) 2
Turkish (2) 2
Czech (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Roffi, Marco and Patrono, Carlo and Collet, Jean-Philippe and Mueller, Christian and Valgimigli, Marco and Aneotti, Felicita and Bax, Jeroen J and Borger, Michael A and Brotons, Carlos and Chew, Derek P and Gencer, Baris and Hasenfuss, Gerd and Kjeldsen, Keld and Lancellotti, Patrizio and Landmesser, Ulf and Mehilli, Julinda and Mukherjee, Debabrata and Storey, Robert F and Windecker, Stephan and Baumgartner, Helmut and Gaemperli, Oliver and Achenbach, Stephan and Agewall, Stefan and Badimon, Lina and Baigent, Colin and Bueno, Héctor and Bugiardini, Raffaele and Carerj, Scipione and Casselman, Filip and Cuisset, Thomas and Erol, Çetin and Fitzsimons, Donna and Halle, Martin and Hamm, Christian and Hildick-Smith, David and Huber, Kurt and Ilioomitis, Efstathios and James, Stefan and Lewis, Basil S and Lip, Gregory Y. H and Piepoli, Massimo F and Richter, Dimitrios and Rosemann, Thomas and Sechtem, Udo and Steg, Ph Gabriel and Vrints, Christian and Luis Zamorano, Jose and Zamorano, Jose Luis and Aboyans, Victor and Barón-Esquivias, Gonzalo and Dean, Veronica and Kirchhof, Paulus and Kolh, Philippe and Nihoyannopoulos, Petros and Ponikowski, Piotr and Torbicki, Adam and Vaz Carneiro, Antonio and Chilingaryan, Aram and Weidinger, Franz and Najafov, Ruslan and Sinnaeve, Peter R and Terzić, Ibrahim and Postadzhiyan, Arman and Milicić, Davor and Eftychiou, Christos and Widimsky, Petr and Bang, Lia and El Etriby, Adel and Marandi, Toomas and Pietilä, Mikko and Kedev, Sasko and Koning, René and Aladashvili, Alexander and Neumann, Franz-Josef and Tsioufis, Kostantinos and Becker, Dávid and Guõnason, Thorarinn and Matetzky, Shlomi and Bolognese, Leonardo and Mussagaliyeva, Aisulu and Beishenkulov, Medet and Latkovskis, Gustavs and Serpytis, Pranas and Pereira, Bruno and Magri, Jane and Grosu, Aurel and Abir-Khalil, Saadia and Larsen, Alf Inge and Budaj, Anzej and Mimoso, Jorge M. Vieira and Ginghina, Carmen and Averkov, Oleg and Nedeljkovic, Milan A and Studencan, Martin and Barrabés, José A and Held, Claes and Rickli, Hans and Peters, Ron J. G and Mourali, Mohamed Sami and Atalar, Enver and ... and ESC Scientific Document Group and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala kliniska forskningscentrum (UCR)
European heart journal, ISSN 0195-668X, 2016, Volume 37, Issue 3, pp. 267 - +
Cangrelor | Angioplasty | Anticoagulation | Bivalirudin | Nitrates | Rhythm monitoring | Dabigatran | Platelet inhibition | Stent | European society of cardiology | Guidelines | Recommendations | Rivaroxaban | Vorapaxar | Apixaban | Fondaparinux | Ticagrelor | Revascularization | Aspirin | Acute cardiac care | Unstable angina | Enoxaparin | Myocardial ischaemia | Beta-blockers | High-sensitivity troponin | Statin | Atherothrombosis | Glycoprotein IIb/IIIa inhibitors | Prasugrel | Early invasive strategy | Clopidogrel | Non-ST-elevation myocardial infarction | Bypass surgery | Chest pain unit | Diabetes | Heparin | Acute coronary syndromes | CARDIAC & CARDIOVASCULAR SYSTEMS | AMERICAN-HEART-ASSOCIATION | MOLECULAR-WEIGHT HEPARIN | ACUTE MYOCARDIAL-INFARCTION | ARTERY-BYPASS SURGERY | DUAL-ANTIPLATELET THERAPY | BARE-METAL STENTS | ACUTE CHEST-PAIN | European Society of Cardiology | SENSITIVITY CARDIAC TROPONIN | DRUG-ELUTING STENTS | Biomarkers - metabolism | Risk Assessment - methods | Diagnosis, Differential | Physical Examination - methods | Humans | Anticoagulants - therapeutic use | Hemorrhage - prevention & control | Long-Term Care | Angina Pectoris - etiology | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Cardiotonic Agents - therapeutic use | Algorithms | Coronary Angiography - methods | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - diagnosis | Electrocardiography | Non-ST Elevated Myocardial Infarction - therapy | Acute Coronary Syndrome - therapy | Platelet Aggregation Inhibitors - therapeutic use | Non-ST Elevated Myocardial Infarction - diagnosis | Purinergic P2Y Receptor Antagonists - therapeutic use | Index Medicus | Anticoagulants | Risk Assessment | Angina Pectoris | Platelet Glycoprotein GPIIb-IIIa Complex | Hemorrhage | Cardiotonic Agents | Life Sciences | Coronary Angiography | Human health and pathology | Non-ST Elevated Myocardial Infarction | Platelet Aggregation Inhibitors | Biomarkers | Physical Examination | Purinergic P2Y Receptor Antagonists | Percutaneous Coronary Intervention | Cardiology and cardiovascular system | Acute Coronary Syndrome | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2193 - 2204
Summary Background Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes. Methods... 
Internal Medicine | HARMONIZING OUTCOMES | MEDICINE, GENERAL & INTERNAL | BLOOD-TRANSFUSION | DOUBLE-BLIND | FOLLOW-UP | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PREMATURE DISCONTINUATION | INTERVENTION | ANTIPLATELET THERAPY | CLINICAL-OUTCOMES | Confidence Intervals | Myocardial Infarction - mortality | Paclitaxel - pharmacology | Prospective Studies | Follow-Up Studies | Humans | Heparin - administration & dosage | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Myocardial Infarction - therapy | Platelet Glycoprotein GPIIb-IIIa Complex - administration & dosage | Time Factors | Electrocardiography | Female | Drug Therapy, Combination | Stents | Angioplasty, Balloon - methods | Myocardial Infarction - diagnosis | Drug-Eluting Stents | Drug Administration Schedule | Peptide Fragments - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Angioplasty, Balloon - mortality | Hirudins - adverse effects | Survival Analysis | Peptide Fragments - adverse effects | Bivalirudin | Research | Diagnosis | Heparin | Drug therapy | Comparative analysis | Health aspects | Heart attack | Heart attacks | Cardiology | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Circulation Research, ISSN 0009-7330, 07/2006, Volume 99, Issue 1, pp. 25 - 33
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2010, Volume 362, Issue 18, pp. 1663 - 1674
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 21, pp. 2218 - 2230
Bivalirudin is a direct thrombin inhibitor. As compared with a combination of heparin and a glycoprotein IIb/IIIa inhibitor, bivalirudin use resulted in less... 
MEDICINE, GENERAL & INTERNAL | IMPACT | THERAPY | GLYCOPROTEIN IIB/IIIA BLOCKADE | BLOOD-TRANSFUSION | ACUTE CORONARY SYNDROMES | RANDOMIZED CONTROLLED-TRIAL | ACUITY TRIAL | INTERVENTION | ABCIXIMAB | CLINICAL-OUTCOMES | Recombinant Proteins - therapeutic use | Recurrence | Myocardial Infarction - mortality | Humans | Middle Aged | Heparin - therapeutic use | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Angioplasty, Balloon, Coronary | Myocardial Infarction - therapy | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Antithrombins - therapeutic use | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Thrombosis - epidemiology | Combined Modality Therapy | Anticoagulants - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Myocardial Infarction - complications | Stroke - etiology | Thrombosis - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Aged | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Stents - adverse effects | Care and treatment | Coronary artery bypass | Bivalirudin | Drug therapy, Combination | Heparin | Comparative analysis | Health aspects | Heart attack | Stroke | Heart attacks | Ischemia | Cardiology | Index Medicus | Abridged Index Medicus
Journal Article